DLA PIPER LLP (US) for BIOGEN, INC.
What was lobbied
6 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Issues related to tax reform.
| Lobbyist | Covered position, as disclosed |
|---|---|
| RICHARD BURR | — |
| KARINA LYNCH | — |
Trade (domestic/foreign) TRD
Trade-related public policy around tariffs and intellectual property.
| Lobbyist | Covered position, as disclosed |
|---|---|
| RICHARD BURR | — |
| KARINA LYNCH | — |
| MICHAEL SORENSEN | — |
Health Issues HCR
Issues related to rare diseases including Alzheimer's disease, Amyotrophic lateral sclerosis (ALS), Lou Gehrig's Disease. Drug pricing and drug development policies. Screening and diagnosis. Patient affordability and access issues, including copay cards, copay accumulators, copay maximizers, coverage issues. Orphan Drug Act. Issues related to the FDA including PDUFA, drug reviews, approval pathways, and clinical trials. Policies related to value based arrangements.
| Lobbyist | Covered position, as disclosed |
|---|---|
| RICHARD BURR | — |
| KARINA LYNCH | — |
| MARGARET MARTIN | — |
| MAREN MCBRIDE | — |
| RACHEL PORTMAN | — |
| MICHAEL SORENSEN | — |
Medical/Disease Research/Clinical Labs MED
Issues related to rare disease and treatment. Drug pricing policy. Issues related to the Medicaid 340B program. Public policy around patients' access and affordability. Alzheimer's disease. Issues related to Medicare Part B and D.
| Lobbyist | Covered position, as disclosed |
|---|---|
| RICHARD BURR | — |
| KARINA LYNCH | — |
| MARGARET MARTIN | — |
| MAREN MCBRIDE | — |
| RACHEL PORTMAN | — |
| MICHAEL SORENSEN | — |
Pharmacy PHA
Issues relating to drug pricing policy. Pharmacy benefit manager legislation related to patient access to therapies.
| Lobbyist | Covered position, as disclosed |
|---|---|
| RICHARD BURR | — |
| KARINA LYNCH | — |
| MARGARET MARTIN | — |
| MICHAEL SORENSEN | — |
Copyright/Patent/Trademark CPT
Intellectual property protections and enforcement. Biopharmaceutical patent policy.
| Lobbyist | Covered position, as disclosed |
|---|---|
| RICHARD BURR | — |
| KARINA LYNCH | — |
| MARGARET MARTIN | — |
| MICHAEL SORENSEN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.